Harvard Wants USPTO Mouse-Testing Patent Ruling Revisited

Law360, Los Angeles (June 12, 2013, 4:05 PM EDT) -- Harvard University and DuPont Co. asked a Virginia federal court Tuesday to reconsider its decision to toss the plaintiffs’ challenge to a U.S. Patent and Trademark Office ruling that a patent for a clinical testing method using transgenic mice had expired.

The move came a month after U.S. District Judge Liam O’Grady ruled that the USPTO decision was reasonable and based on available evidence. The USPTO had not violated the Administrative Procedure Act when it determined that the disputed patent — U.S. Patent Number 5,925,803, owned...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.